MedTrace Logo

Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis

NCT00426621 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2007-12-18

No results posted yet for this study

Summary

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.

Conditions

  • Osteoarthritis of the Knee

Interventions

DRUG

Diclofenac Sodium Gel

4 grams per knee, 4 times per day, for 12 weeks

DRUG

Placebo

4 grams per knee, 4 times per day, for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • Roy Altman, MD · University of California, in Los Angeles, Division of Rheumatology, 310 206 7866

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00426621 on ClinicalTrials.gov